These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2743271)

  • 1. A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol).
    Ferrara F; Del Vecchio L; Mele G; Rametta V; Ronconi F; Montuori R
    Cancer; 1989 Aug; 64(4):789-92. PubMed ID: 2743271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interferon-alpha 2A as maintenance treatment for patients with advanced stage chronic lymphocytic leukemia responding to chemotherapy.
    Ferrara F; Rametta V; Mele G; Antinolfi I; Mettivier V; Cimino R
    Am J Hematol; 1992 Sep; 41(1):45-9. PubMed ID: 1503098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse well-differentiated lymphocytic lymphoma: chemotherapy with BCNU, cyclophosphamide, vincristine, melphalan and prednisone.
    Case DC; Boyd M; Hayes DM; Dorsk BM
    Oncology; 1988; 45(6):417-20. PubMed ID: 3054672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with the M-2 protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for chronic lymphocytic leukemia (stages III and IV).
    Case DC; Porensky RS; Fanning JP
    Oncology; 1985; 42(6):350-3. PubMed ID: 4069549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
    Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
    Binet JL
    Hematol Oncol; 1993; 11 Suppl 1():38. PubMed ID: 8486339
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.
    Raphael B; Andersen JW; Silber R; Oken M; Moore D; Bennett J; Bonner H; Hahn R; Knospe WH; Mazza J
    J Clin Oncol; 1991 May; 9(5):770-6. PubMed ID: 2016618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone.
    Bowen DA; Call TG; Shanafelt TD; Kay NE; Schwager SM; Reinalda MS; Rabe KG; Slager SL; Zent CS
    Leuk Lymphoma; 2010 Apr; 51(4):620-7. PubMed ID: 20302386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).
    Kempin S; Lee BJ; Thaler HT; Koziner B; Hecht S; Gee T; Arlin Z; Little C; Straus D; Reich L; Phillips E; Al-Mondhiry H; Dowling M; Mayer K; Clarkson B
    Blood; 1982 Nov; 60(5):1110-21. PubMed ID: 6751436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptichemio, vincristine and prednisone versus melphalan and prednisone as induction therapy in multiple myeloma.
    Riccardi A; Merlini G; Montecucco C; Danova M; Ucci G; Cassano E; Ascari E
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):787-91. PubMed ID: 3770037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
    Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
    Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.
    Brugnatelli S; Riccardi A; Ucci G; Mora O; Barbarano L; Piva N; Piccinini L; Bergonzi C; De Paoli A; Di Stasi M; Rinaldi E; Trotti G; Petrini M; Ascari E
    Br J Cancer; 1996 Mar; 73(6):794-7. PubMed ID: 8611382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
    Dreger P; von Neuhoff N; Kuse R; Sonnen R; Glass B; Uharek L; Schoch R; Löffler H; Schmitz N
    Br J Cancer; 1998 Jun; 77(12):2291-7. PubMed ID: 9649148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group.
    J Natl Cancer Inst; 1999 May; 91(10):861-8. PubMed ID: 10340906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete remission in plasma cell leukaemia.
    Montecucco C; Riccardi A; Merlini G; Ascari E
    Br J Haematol; 1986 Mar; 62(3):525-7. PubMed ID: 3954966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
    Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
    Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptichemio, vincristine, prednisone induction treatment in multiple myeloma.
    Merlini G; Riccardi A; Riccardi PG; Montecucco CM; Pavesi F; Ascari E
    Tumori; 1985 Dec; 71(6):581-8. PubMed ID: 4082291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C.
    Montserrat E; Alcalá A; Alonso C; Besalduch J; Moraleda JM; García-Conde J; Gutierrez M; Gomis F; Garijo J; Guzmán MC
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):429-32. PubMed ID: 3065738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.